203 related articles for article (PubMed ID: 21041972)
1. Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-.
Liu Y; Imanishi T; Kubo T; Tanaka A; Kitabata H; Tanimoto T; Ino Y; Ikejima H; Tsujioka H; Komukai K; Ishibashi K; Kashiwagi M; Ozaki Y; Hirata K; Mizukoshi M; Akasaka T
Circ J; 2011; 75(1):106-12. PubMed ID: 21041972
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
3. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Naka KK; Fotiadis DI; Michalis LK
JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755
[TBL] [Abstract][Full Text] [Related]
4. Neointimal coverage over coronary stent struts crossing the side branch Ostia.
Sakata Y
Circ J; 2011; 75(1):51-2. PubMed ID: 21173501
[No Abstract] [Full Text] [Related]
5. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.
Kim JS; Kim JS; Kim TH; Fan C; Lee JM; Kim W; Ko YG; Choi D; Hong MK; Jang Y
Circ J; 2010 Feb; 74(2):320-6. PubMed ID: 20019414
[TBL] [Abstract][Full Text] [Related]
6. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of neointimal coverage of sirolimus-eluting stents--evaluation with optical coherence tomography.
Ishigami K; Uemura S; Morikawa Y; Soeda T; Okayama S; Nishida T; Takemoto Y; Onoue K; Somekawa S; Takeda Y; Kawata H; Horii M; Saito Y
Circ J; 2009 Dec; 73(12):2300-7. PubMed ID: 19789417
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
9. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
[TBL] [Abstract][Full Text] [Related]
10. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
[TBL] [Abstract][Full Text] [Related]
11. Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.
Kim TH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2011 Jul; 27(6):875-81. PubMed ID: 20978851
[TBL] [Abstract][Full Text] [Related]
12. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
13. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
[TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
[TBL] [Abstract][Full Text] [Related]
15. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
[TBL] [Abstract][Full Text] [Related]
16. Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography.
Ikuta S; Kobuke K; Iwanaga Y; Nakauchi Y; Yamaji K; Miyazaki S
Heart Vessels; 2014 May; 29(3):320-7. PubMed ID: 23793881
[TBL] [Abstract][Full Text] [Related]
17. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
18. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography.
Chen BX; Ma FY; Luo W; Ruan JH; Xie WL; Zhao XZ; Sun SH; Guo XM; Wang F; Tian T; Chu XW
Heart; 2008 May; 94(5):566-70. PubMed ID: 17923466
[TBL] [Abstract][Full Text] [Related]
19. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.
Kim BK; Kim JS; Oh C; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):705-14. PubMed ID: 21626042
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations.
Kyono H; Guagliumi G; Sirbu V; Rosenthal N; Tahara S; Musumeci G; Trivisonno A; Bezerra HG; Costa MA
EuroIntervention; 2010 May; 6(1):69-77. PubMed ID: 20542800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
